Survival impact of lymphadenectomy stratified by nodal metastatic probability in endometrial cancer

Annals of Surgical Oncology

Volumn 21, Issue 7, 2014, Pages 2376-2382

  Koskas, Martin ^a,b,c,d   Fournier, Marie ^a   Luton, Dominique ^a,c   Darai, Emile ^d,e   Rouzier, Roman ^b,f  

^a BICHAT HOSPITAL   (France)

^b Risques Cliniques et Securite en Sante des Femmes et en Sante Perinatale   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^e HÔPITAL TENON   (France)

^f INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HISTOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NOMOGRAM; PREDICTION; PROBABILITY; SURVIVAL RATE; ADENOCARCINOMA, CLEAR CELL; ADOLESCENT; CANCER GRADING; CANCER REGISTRY; CARCINOMA, PAPILLARY; CARCINOSARCOMA; CASE CONTROL STUDY; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FOLLOW UP; FRANCE; LYMPH NODE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; SECONDARY; TUMOR INVASION; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA, CLEAR CELL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CARCINOSARCOMA; CASE-CONTROL STUDIES; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NOMOGRAMS; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; YOUNG ADULT;

EID: 84902143607     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3589-6     Document Type: Article

References (17)

1. Bendifallah S, Genin AS, Naoura I, et al. A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer. Am J Obstet Gynecol. 2012;207:197 e1-8.
2. Koskas M, Chabbert-Buffet N, Bendifallah S, Luton D, Clavel-Chapelon F, Rouzier R. Prognostic value of the 2009 FIGO staging for endometrial cancer: an illustration of the E3N cohort. Int J Gynecol Cancer. 2012;22:447-51.
3. Hoekstra AV, Kim RJ, Small W Jr, et al. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes. Gynecol Oncol. 2009;114:273-8.
4. Cragun JM, Havrilesky LJ, Calingaert B, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005;23:3668-75.
5. Katz LA, Andrews SJ, Fanning J. Survival after multimodality treatment for stage IIIC endometrial cancer. Am J Obstet Gynecol. 2001;184:1071-3.
6. Bristow RE, Zahurak ML, Alexander CJ, Zellars RC, Montz FJ. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int J Gynecol Cancer. 2003;13:664-72.
7. Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707-16.
8. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125-36.
9. Chan JK, Cheung MK, Huh WK, et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer. 2006;107:1823-30.
10. Barrena Medel NI, Herzog TJ, Deutsch I, et al. Comparison of the prognostic significance of uterine factors and nodal status for endometrial cancer. Am J Obstet Gynecol. 2011;204:248 e1-7.
11. Creutzberg CL, Van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicenter randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404-11.
12. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744-51.
13. Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol. 1980;56:419-27.
14. Blake P, Swart AM, Orton J, et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet. 2009;373:137-46.
15. Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010;375:816-23.
16. Bendifallah S, Koskas M, Ballester M, Genin AS, Darai E, Rouzier R. The survival impact of systematic lymphadenectomy in endometrial cancer with the use of propensity score matching analysis. Am J Obstet Gynecol. 2012;206:1-11.
17. Giuntoli RL 2nd, Gerardi MA, Yemelyanova AV, et al. Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival. Int J Gynecol Cancer. 2012;22:273-9.